Publications by authors named "S Lebdai"

Claim this Profile
A
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).
M Roupret, A Bertaut, G Pignot, Y Neuzillet, N Houede, S Lebdai

Ann Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of renal function after ureteroscopy in solitary kidney.
Charles Jaouen, Olivier Traxer, Stefano Moretto, Federico Zorzi, Alberto Quarà, Souhil Lebdai

World J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-interventional and medical management of lower urinary tract symptoms related to benign prostatic hyperplasia in men: Guidelines of the French LUTS Committee (CTMH).
Julien Anract, Clément Klein, Clément Sarrazin, Ugo Pinar, Armand Chevrot, Souhil Lebdai

Fr J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical and interventional management of bladder outlet obstruction related to benign prostatic hyperplasia: Systematic review of the literature and Clinical Practice Guidelines from the French Male LUTS Committee (CTMH).
Clément Klein, Julien Anract, Ugo Pinar, Armand Chevrot, Emmanuel Della Negra, Souhil Lebdai

Fr J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of acute urinary retention in men with benign prostatic hyperplasia: Literature review and guidelines from the French Urological Association Male LUTS Panel (CTMH).
Ugo Pinar, Jérôme Gas, Clément Sarrazin, Julien Anract, Armand Chevrot, Souhil Lebdai

Fr J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis